TL Genomics Company

TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.
Technology: Pregnancy biomarkers
Industry: Molecular
Headquarters: Koganei, Tokyo, Japan
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: $3,800,000.00
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-05-07
Last Funding Type: Series B

Visit Website
Register and Claim Ownership